BismuthSubcitrateMetronidazoleTetracycline_GastroFDCQualityChecker

Bismuth/Metronidazole/Tetracycline Gastro FDC Quality Checker

CSV→JSON FDC Gastroenterology MissingAPI P2 QC URS & FS missing_api_2026
Open selection
Bismuth/Metronidazole/Tetracycline Gastro FDC Quality Checker — Combination Gastroenterological Product Quality Control

ℹ️ Utility checks critical parameters of H. pylori eradication combination:
• Bismuth Assay: 90.0–110.0%
• Metronidazole Assay: 90.0–110.0%
• Tetracycline Assay: 90.0–110.0%
• Metronidazole Impurities: ≤1.0%
• Tetracycline Impurities: ≤1.0%
• Total Impurities: ≤2.5%
• Dissolution of each component: ≥85% (Q)
• Moisture Content: ≤5.0%
• Heavy Metals: ≤20 ppm

⚠️ CRITICAL: Tetracycline is sensitive to light and moisture (epi-tetracycline formation).
Bismuth may interact with other components at high humidity.

Usage:
BismuthSubcitrateMetronidazoleTetracycline_GastroFDCQualityChecker.exe → demo mode
BismuthSubcitrateMetronidazoleTetracycline_GastroFDCQualityChecker.exe input.csv output.json → evaluate data

Input format:
BatchNumber,BismuthAssayPercent,MetronidazoleAssayPercent,TetracyclineAssayPercent,MetronidazoleImpurityPercent,TetracyclineImpurityPercent,TotalImpuritiesPercent,DissolutionMetronidazolePercent,DissolutionTetracyclinePercent,MoistureContentPercent,HeavyMetalsPPM

Example:
BMT-2026-001,100.5,99.8,100.2,0.3,0.4,0.9,95.0,92.0,3.5,8.0

— WHY IS THIS NEEDED?
Bismuth subcitrate, metronidazole, and tetracycline combination is used for Helicobacter pylori eradication:
• Bismuth subcitrate — gastroprotective and antibacterial action
• Metronidazole — antiprotozoal and antibacterial drug
• Tetracycline — broad-spectrum antibiotic
• Combination is part of first-line quadruple therapy for clarithromycin resistance
• Tetracycline is chemically unstable (epimerization, oxidation)

⚠️ CRITICAL:
• Assay 90.0–110.0% for each component — ensures eradication efficacy
• Metronidazole and Tetracycline impurities ≤1.0% — degradation and synthesis products
• Total Impurities ≤2.5% — overall purity indicator
• Dissolution ≥85% for each component — ensures bioavailability
• Moisture Content ≤5.0% — critical for tetracycline stability
• Heavy Metals ≤20 ppm — drug safety

Key features:
• Simultaneous check of three active substances with different mechanisms of action
• Individual impurity control considering tetracycline instability
• Dissolution testing for both organic components
• Moisture control as stability factor for tetracycline

Critical parameters:
• Bismuth Assay: 90.0–110.0%
• Metronidazole Assay: 90.0–110.0%
• Tetracycline Assay: 90.0–110.0%
• Metronidazole Impurities: ≤1.0%
• Tetracycline Impurities: ≤1.0%
• Total Impurities: ≤2.5%
• Dissolution (each): ≥85% (Q)
• Moisture Content: ≤5.0%
• Heavy Metals: ≤20 ppm

💡 Usage tips:
1. Assay determined by HPLC with UV detection (for organic components) and atomic absorption/titration (for bismuth)
2. Protect tetracycline from light during sample preparation
3. Tetracycline dissolution may require use of buffer media
4. Moisture determined by Karl Fischer method
5. Store in airtight packaging, protect from light
6. If high levels of tetracycline impurities detected, check raw material storage conditions (risk of toxic epi-forms)

⚠️ Note: Tetracycline is prone to epimerization forming epi-tetracycline, which is less active and more toxic. This process accelerates in humid environments and upon heating. Bismuth may form complexes with tetracycline, requiring careful control of manufacturing process and mixture homogeneity.

input.csv

BatchNumber,BismuthAssayPercent,MetronidazoleAssayPercent,TetracyclineAssayPercent,MetronidazoleImpurityPercent,TetracyclineImpurityPercent,TotalImpuritiesPercent,DissolutionMetronidazolePercent,DissolutionTetracyclinePercent,MoistureContentPercent,HeavyMetalsPPM
BMT-2026-001,100.5,99.8,100.2,0.3,0.4,0.9,95.0,92.0,3.5,8.0
BMT-2026-002,98.0,101.0,99.5,0.5,0.6,1.3,93.0,90.0,4.2,10.0

BismuthSubcitrateMetronidazoleTetracycline_GastroFDCQualityChecker — Documentation

Bilingual RU/EN URS & FS. Source: input.csv and *.description.txt. Package folder: Gastroenterology QC Suite.
Utility
BismuthSubcitrateMetronidazoleTetracycline_GastroFDCQualityChecker
Package
Gastroenterology QC Suite
CSV fields
11
Interface
CSV → JSON

Utility description

Bismuth/Metronidazole/Tetracycline Gastro FDC Quality Checker — Combination Gastroenterological Product Quality Control

ℹ️  Utility checks critical parameters of H. pylori eradication combination:
    • Bismuth Assay: 90.0–110.0%
    • Metronidazole Assay: 90.0–110.0%
    • Tetracycline Assay: 90.0–110.0%
    • Metronidazole Impurities: ≤1.0%
    • Tetracycline Impurities: ≤1.0%
    • Total Impurities: ≤2.5%
    • Dissolution of each component: ≥85% (Q)
    • Moisture Content: ≤5.0%
    • Heavy Metals: ≤20 ppm

⚠️  CRITICAL: Tetracycline is sensitive to light and moisture (epi-tetracycline formation).
    Bismuth may interact with other components at high humidity.

Usage:
  BismuthSubcitrateMetronidazoleTetracycline_GastroFDCQualityChecker.exe                            → demo mode
  BismuthSubcitrateMetronidazoleTetracycline_GastroFDCQualityChecker.exe input.csv output.json      → evaluate data

Input format:
BatchNumber,BismuthAssayPercent,MetronidazoleAssayPercent,TetracyclineAssayPercent,MetronidazoleImpurityPercent,TetracyclineImpurityPercent,TotalImpuritiesPercent,DissolutionMetronidazolePercent,DissolutionTetracyclinePercent,MoistureContentPercent,HeavyMetalsPPM

Example:
  BMT-2026-001,100.5,99.8,100.2,0.3,0.4,0.9,95.0,92.0,3.5,8.0

— WHY IS THIS NEEDED?
Bismuth subcitrate, metronidazole, and tetracycline combination is used for Helicobacter pylori eradication:
• Bismuth subcitrate — gastroprotective and antibacterial action
• Metronidazole — antiprotozoal and antibacterial drug
• Tetracycline — broad-spectrum antibiotic
• Combination is part of first-line quadruple therapy for clarithromycin resistance
• Tetracycline is chemically unstable (epimerization, oxidation)

⚠️  CRITICAL:
• Assay 90.0–110.0% for each component — ensures eradication efficacy
• Metronidazole and Tetracycline impurities ≤1.0% — degradation and synthesis products
• Total Impurities ≤2.5% — overall purity indicator
• Dissolution ≥85% for each component — ensures bioavailability
• Moisture Content ≤5.0% — critical for tetracycline stability
• Heavy Metals ≤20 ppm — drug safety

Key features:
• Simultaneous check of three active substances with different mechanisms of action
• Individual impurity control considering tetracycline instability
• Dissolution testing for both organic components
• Moisture control as stability factor for tetracycline

Critical parameters:
• Bismuth Assay: 90.0–110.0%
• Metronidazole Assay: 90.0–110.0%
• Tetracycline Assay: 90.0–110.0%
• Metronidazole Impurities: ≤1.0%
• Tetracycline Impurities: ≤1.0%
• Total Impurities: ≤2.5%
• Dissolution (each): ≥85% (Q)
• Moisture Content: ≤5.0%
• Heavy Metals: ≤20 ppm

💡 Usage tips:
1. Assay determined by HPLC with UV detection (for organic components) and atomic absorption/titration (for bismuth)
2. Protect tetracycline from light during sample preparation
3. Tetracycline dissolution may require use of buffer media
4. Moisture determined by Karl Fischer method
5. Store in airtight packaging, protect from light
6. If high levels of tetracycline impurities detected, check raw material storage conditions (risk of toxic epi-forms)

⚠️ Note: Tetracycline is prone to epimerization forming epi-tetracycline, which is less active and more toxic. This process accelerates in humid environments and upon heating. Bismuth may form complexes with tetracycline, requiring careful control of manufacturing process and mixture homogeneity.

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of BismuthSubcitrateMetronidazoleTetracycline_GastroFDCQualityChecker for Bismuth/Metronidazole/Tetracycline Gastro FDC Quality Checker.

Portal packages

Gastroenterology QC Suite, Global/API coverage extension, LabEx QC laboratory utilities, Lumex QC instrument utilities, World API/FDC extension

CSV→JSONFDCGastroenterologyMissingAPIQCURS & FSP2

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.
  • ℹ️ Utility checks critical parameters of H. pylori eradication combination:
  • • Bismuth Assay: 90.0–110.0%
  • • Metronidazole Assay: 90.0–110.0%
  • • Tetracycline Assay: 90.0–110.0%
  • • Metronidazole Impurities: ≤1.0%
  • • Tetracycline Impurities: ≤1.0%
  • • Total Impurities: ≤2.5%
  • • Dissolution of each component: ≥85% (Q)
  • • Moisture Content: ≤5.0%
  • • Heavy Metals: ≤20 ppm
  • ⚠️ CRITICAL: Tetracycline is sensitive to light and moisture (epi-tetracycline formation).
  • BatchNumber,BismuthAssayPercent,MetronidazoleAssayPercent,TetracyclineAssayPercent,MetronidazoleImpurityPercent,TetracyclineImpurityPercent,TotalImpuritiesPercent,DissolutionMetronidazolePercent,DissolutionTetracyclinePercent,MoistureContentPercent,HeavyMetalsPPM
  • ⚠️ CRITICAL:
  • • Assay 90.0–110.0% for each component — ensures eradication efficacy
  • • Metronidazole and Tetracycline impurities ≤1.0% — degradation and synthesis products
  • • Total Impurities ≤2.5% — overall purity indicator
  • • Dissolution ≥85% for each component — ensures bioavailability
  • • Moisture Content ≤5.0% — critical for tetracycline stability

URS — User Requirements Specification

IDRequirementCriticalityAcceptance criterion
URS-001The utility shall accept an input.csv file for Bismuth/Metronidazole/Tetracycline Gastro FDC Quality Checker with headers defined in the data contract.HighThe file is processed without manual header editing.
URS-002The utility shall perform deterministic QC evaluation without machine learning and without probabilistic conformance decisions.HighIdentical input data, rule version and configuration produce reproducible results.
URS-003The utility shall validate mandatory fields, data types, ranges, units and domain plausibility.HighSchema, conversion and range errors are explicitly reported.
URS-004The utility shall apply domain limits and rules from the description, approved specification, registration dossier and local SOPs.HighEach check has PASS/WARNING/FAIL and a clear message.
URS-005The utility shall generate output.json with machine-readable results, source values, warnings, failures and critical findings.HighJSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006The utility shall preserve traceability between batch/sample, input file, applied rules and final status.HighOutput contains identifiers, checked parameters and audit metadata.
URS-007The documentation shall support IQ/OQ/PQ, CSV/CSA and review by internal QA or inspectors.MediumURS, FS, input/output contract and test scenarios are supplied with the utility.
URS-008The utility shall be used as a QC decision-support tool and not as a substitute for approved specifications and QA/QP release decision.MediumDocumentation states change control and limit-verification expectations.

input.csv contract

#FieldTypeSamplePurpose
1BatchNumberstring / controlled vocabularyBMT-2026-001Batch or lot identifier used for traceability.
2BismuthAssayPercentdecimal100.5Quantitative content/potency; critical release parameter.
3MetronidazoleAssayPercentdecimal99.8Quantitative content/potency; critical release parameter.
4TetracyclineAssayPercentdecimal100.2Quantitative content/potency; critical release parameter.
5MetronidazoleImpurityPercentdecimal0.3Impurity/related-substance parameter; purity and degradation control.
6TetracyclineImpurityPercentdecimal0.4Impurity/related-substance parameter; purity and degradation control.
7TotalImpuritiesPercentdecimal0.9Impurity/related-substance parameter; purity and degradation control.
8DissolutionMetronidazolePercentdecimal95.0Dissolution/release parameter relevant to bioavailability and batch quality.
9DissolutionTetracyclinePercentdecimal92.0Dissolution/release parameter relevant to bioavailability and batch quality.
10MoistureContentPercentdecimal3.5Quantitative content/potency; critical release parameter.
11HeavyMetalsPPMdecimal8.0Elemental impurity/metal parameter relevant to safety.
BatchNumber,BismuthAssayPercent,MetronidazoleAssayPercent,TetracyclineAssayPercent,MetronidazoleImpurityPercent,TetracyclineImpurityPercent,TotalImpuritiesPercent,DissolutionMetronidazolePercent,DissolutionTetracyclinePercent,MoistureContentPercent,HeavyMetalsPPM
BMT-2026-001,100.5,99.8,100.2,0.3,0.4,0.9,95.0,92.0,3.5,8.0
BMT-2026-002,98.0,101.0,99.5,0.5,0.6,1.3,93.0,90.0,4.2,10.0

Input validation rules

IDFieldRuleCriticality
VR-001BatchNumberThe field shall match an approved dictionary or accepted string representation.High
VR-002BismuthAssayPercentThe value shall be numeric, non-empty and domain-plausible for the approved specification.High
VR-003MetronidazoleAssayPercentThe value shall be numeric, non-empty and domain-plausible for the approved specification.High
VR-004TetracyclineAssayPercentThe value shall be numeric, non-empty and domain-plausible for the approved specification.High
VR-005MetronidazoleImpurityPercentThe value shall be numeric, non-empty and domain-plausible for the approved specification.High
VR-006TetracyclineImpurityPercentThe value shall be numeric, non-empty and domain-plausible for the approved specification.High
VR-007TotalImpuritiesPercentThe value shall be numeric, non-empty and domain-plausible for the approved specification.High
VR-008DissolutionMetronidazolePercentThe value shall be numeric, non-empty and domain-plausible for the approved specification.Medium
VR-009DissolutionTetracyclinePercentThe value shall be numeric, non-empty and domain-plausible for the approved specification.Medium
VR-010MoistureContentPercentThe value shall be numeric, non-empty and domain-plausible for the approved specification.High
VR-011HeavyMetalsPPMThe value shall be numeric, non-empty and domain-plausible for the approved specification.Medium

FS — Functional Specification

IDFunctionImplementation
FS-001CLI executionSupport execution modes: demo mode without arguments and production mode input.csv output.json.
FS-002CSV importRead input.csv in UTF-8/CSV-compatible format and validate header and expected columns.
FS-003Schema validationCheck mandatory fields, column count, unknown key fields and empty mandatory values.
FS-004Type conversionConvert numeric, flag and text values; invalid format is recorded as a row-level error.
FS-005Domain rule engineApply rules for Bismuth/Metronidazole/Tetracycline Gastro FDC Quality Checker, including critical limits from the description and approved specification.
FS-006Status aggregationProduce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-007JSON exportWrite output.json with detailed checks, source values, warnings, failures and critical findings.
FS-008Audit supportKeep result structure suitable for review, deviation investigation and calculation reproduction.
FS-009Integration contractSupport the scenario LIMS/ELN/MES → input.csv → utility → output.json → portal/admin review.
FS-010Fallback mappingIf the combined utility is not deployed, use component checks: bismuth-subcitrate-quality-checker, metronidazole-quality-checker, tetracycline-quality-checker plus generic Lumex/LabEx checks.
FS-011Error handlingReturn explicit messages for missing file, empty CSV, invalid schema, output write failure and invalid format.

Example output.json

{
  "utilityId": "bismuth-subcitrate-metronidazole-tetracycline-gastro-fdc-quality-checker",
  "utilityFolder": "BismuthSubcitrateMetronidazoleTetracycline_GastroFDCQualityChecker",
  "package": "Gastroenterology QC Suite",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "processedAtUtc": "2026-07-02T00:00:00Z",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "BMT-2026-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-001"
    },
    {
      "parameter": "BismuthAssayPercent",
      "value": "100.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-002"
    },
    {
      "parameter": "MetronidazoleAssayPercent",
      "value": "99.8",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-003"
    },
    {
      "parameter": "TetracyclineAssayPercent",
      "value": "100.2",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-004"
    },
    {
      "parameter": "MetronidazoleImpurityPercent",
      "value": "0.3",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-005"
    },
    {
      "parameter": "TetracyclineImpurityPercent",
      "value": "0.4",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-006"
    },
    {
      "parameter": "TotalImpuritiesPercent",
      "value": "0.9",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-007"
    },
    {
      "parameter": "DissolutionMetronidazolePercent",
      "value": "95.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-008"
    },
    {
      "parameter": "DissolutionTetracyclinePercent",
      "value": "92.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-009"
    },
    {
      "parameter": "MoistureContentPercent",
      "value": "3.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-010"
    },
    {
      "parameter": "HeavyMetalsPPM",
      "value": "8.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-011"
    }
  ],
  "criticalFindings": [],
  "warnings": [],
  "audit": {
    "inputHash": "sha256:<calculated at runtime>",
    "rulesVersion": "<utility executable version>",
    "documentation": "BismuthSubcitrateMetronidazoleTetracycline_GastroFDCQualityChecker.documentation.html"
  }
}

Traceability matrix

URSFSTestEvidence
URS-001FS-001, FS-002OQ-001Verify execution and import of valid input.csv.
URS-002FS-005, FS-006OQ-004Repeat the same dataset and compare output.json.
URS-003FS-003, FS-004, FS-011OQ-002, OQ-003Verify missing columns and invalid types.
URS-004FS-005, FS-006OQ-004, PQ-001Verify critical deviations on real/boundary data.
URS-005FS-007, FS-009OQ-005Verify JSON schema and downstream-system suitability.
URS-006FS-008OQ-006Verify identifiers and audit metadata.
URS-007FS-008, FS-011IQ-001, OQ-007Verify documentation completeness and control evidence.
URS-008FS-005, FS-008, FS-010PQ-002Verify review workflow and no replacement of QA decision.

IQ/OQ/PQ test scenarios

IDScenarioExpected result
IQ-001Verify executable, input.csv, documentation and checksum availability.Delivery set is complete; version is recorded.
OQ-001Valid sample row from input.csv.PASS or acceptable WARNING according to rules.
OQ-002Remove a mandatory CSV column.Schema error or FAIL with missing-column reference.
OQ-003Place a non-numeric value into a numeric field.Type-conversion error with row/field reference.
OQ-004Set a critical parameter outside the limit.FAIL and critical finding.
OQ-005Verify output.json structure.All mandatory sections are present and JSON is valid.
OQ-006Verify batch/sample traceability.Input and result identifiers match.
OQ-007Verify fallback/decomposition for combined APIs.Component checks are explicitly documented.
PQ-001Verify 3–5 real user batches/samples.Result is confirmed by QC/QA review.
PQ-002Verify deviation workflow and manual QA decision.Utility supports review but does not replace approved decision.

QA/QC and change control

  • Do not rename columns without updating validator, documentation and test set.
  • Retain input.csv, output.json, executable version and checksum.
  • Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
  • Critical limits shall be verified against the approved specification, registration dossier and local SOPs.
  • For combination products, document whether the specialized FDC utility or fallback component checks were used.
  • The utility provides structured QC decision support; final release decision remains with QA/QP and approved procedures.

Included in packages

Gastroenterology QC Suite

QC package for gastroenterology: PPIs, antiemetics, prokinetics, IBD medicines, laxatives, enzymes and GI anti-infectives.

Open

Global API & Biosimilars QC Suite

Package for high-demand global APIs, generics and biosimilars, including fixed-dose combinations and biological products.

Open

World API Extension QC Suite

Extended package for 130 additional high-demand APIs and biological products prepared as a market-coverage backlog.

Open